✦ LIBER ✦

Exercise as an end-point in pulmonary hypertension trials

✍ Scribed by B. McCullagh; R. E. Girgis

Book ID: 111309169
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 79 KB
Volume: 64
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2009.02231.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End Points and Clinical Trial Design in

End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

✍ Vallerie V. McLaughlin; David B. Badesch; Marion Delcroix; Thomas R. Fleming; Se 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Imaging as an End Point in Ischemia Tria

Imaging as an End Point in Ischemia Trials

✍ Andrew G. Howarth; Matthias G. Friedrich 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 184 KB

Imaging of cardiac function and anatomy has advanced at an exponential rate over the past two decades. Our ability to quantitatively assess the degree of myocardial ischemia and accurately define the vascular anatomy using noninvasive techniques is greater than ever before. Current advances is cardi

End points and clinical trial designs in

End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives

✍ Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila G Hawor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Response as an end point in treatment tr

Response as an end point in treatment trials for acute GVHD

✍ Pavletic, S Z 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 335 KB

Intermediate versus hard end points in c

Intermediate versus hard end points in clinical trials on hypertension

✍ Guido Grassi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 184 KB

Progression-free survival as an end-poin

Progression-free survival as an end-point in clinical trials of biotherapeutic agents

✍ Lothar Bergmann; Steven Hirschfeld; Charles Morris; Sergio Palmeri; Andrew Stone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB